AIM ImmunoTech (AIM) News Today $0.21 +0.02 (+8.42%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period AIM ImmunoTech highlights 2024 milestones achievedJanuary 16 at 8:38 AM | markets.businessinsider.comComparing Mesoblast (NASDAQ:MESO) and AIM ImmunoTech (NYSE:AIM)January 16 at 3:33 AM | americanbankingnews.comAIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving MilestonesJanuary 15, 2025 | globenewswire.comAIM ImmunoTech (NYSE:AIM) & INmune Bio (NASDAQ:INMB) Head-To-Head ReviewJanuary 11, 2025 | americanbankingnews.comAnalyzing AIM ImmunoTech (NYSE:AIM) & Mesoblast (NASDAQ:MESO)January 11, 2025 | americanbankingnews.comTed Kellner low-key on joining pharma firm board he fought to joinDecember 20, 2024 | bizjournals.comAIM ImmunoTech Inc.: AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsDecember 18, 2024 | finanznachrichten.deAIM ImmunoTech receives noncompliance notification from NYSEDecember 18, 2024 | markets.businessinsider.comPharma company proxy fight ends in mixed results for Ted KellnerDecember 17, 2024 | bizjournals.comAIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsDecember 17, 2024 | globenewswire.comAIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual MeetingDecember 17, 2024 | businesswire.comTed Kellner's multimillion-dollar fight to unseat pharma firm's boardDecember 17, 2024 | bizjournals.comAIM ImmunoTech Reminds Shareholders to Vote "FOR" All Four Incumbent Board Members on the WHITE Universal Proxy CardDecember 16, 2024 | tmcnet.comKellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent BoardDecember 14, 2024 | globenewswire.comAIM ImmunoTech gains Netherlands patent for post-Covid fatigue therapyDecember 13, 2024 | finance.yahoo.comAIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card "FOR" All Four Incumbent Board MembersDecember 12, 2024 | tmcnet.comAIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board MembersDecember 12, 2024 | businesswire.comAIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of FatigueDecember 12, 2024 | globenewswire.comKellner Group Announces Support from Another Former AIM Senior ExecutiveDecember 12, 2024 | globenewswire.comAIM’s Clinical Strategy Under Incumbent Board Has Totally FailedDecember 11, 2024 | markets.businessinsider.comAIM's Clinical Strategy Under Incumbent Board Has Totally FailedDecember 11, 2024 | globenewswire.comGlass Lewis Recommends AIM ImmunoTech Shareholders Vote "FOR" Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. MitchellDecember 10, 2024 | uk.finance.yahoo.comGlass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K.December 10, 2024 | businesswire.comAmpligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are ElectedDecember 10, 2024 | globenewswire.comAIM ImmunoTech Participates in Virtual Investor KOL Connect SegmentDecember 6, 2024 | globenewswire.comKellner Group Urges Stockholders of AIM Immunotech to Vote the Gold CardDecember 6, 2024 | globenewswire.comISS Recommends AIM ImmunoTech Shareholders Vote "FOR" Company Nominees Nancy K. Bryan and Dr. William M. MitchellDecember 5, 2024 | finance.yahoo.comAIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the BoardDecember 3, 2024 | finance.yahoo.comKellner Group urges AIM ImmunoTech stockholders to vote for its nomineesDecember 3, 2024 | markets.businessinsider.comKellner Group Urges Stockholders of AIM Immunotech to Vote the Gold CardDecember 2, 2024 | globenewswire.comAIM ImmunoTech announces cash conservation plan, committment to AmpligenNovember 28, 2024 | markets.businessinsider.comAIM ImmunoTech Refutes Activist Group’s False and Misleading ClaimsNovember 28, 2024 | finance.yahoo.comAIM ImmunoTech Aligns Compensation with Shareholder StrategyNovember 27, 2024 | tipranks.comAIM ImmunoTech Refutes Activist Group's False and Misleading ClaimsNovember 27, 2024 | businesswire.comKellner Group isses letter to stockholders of AIM ImmunoTechNovember 26, 2024 | markets.businessinsider.comKellner Group Urges Stockholders of AIM Immunotech to Vote Enclosed Gold CardNovember 26, 2024 | markets.businessinsider.comAIM ImmunoTech Inc. (NYSE:AIM) Director Buys $15,571.07 in StockNovember 22, 2024 | insidertrades.comThomas K. Equels Acquires 60,110 Shares of AIM ImmunoTech Inc. (NYSE:AIM) StockNovember 21, 2024 | insidertrades.comAIM ImmunoTech announces data pubished on Part 1 study on AmpligenNovember 19, 2024 | markets.businessinsider.comKellner Group urgers stockholders of AIM Immunotech to vote for nomineesNovember 19, 2024 | markets.businessinsider.comAIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of CancerNovember 19, 2024 | globenewswire.comAIM ImmunoTech Inc. (AMEX:AIM) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comAIM Down on Q3 ResultsNovember 16, 2024 | baystreet.caAIM ImmunoTech files to sell 9.31M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comAIM ImmunoTech Inc (AIM) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...November 16, 2024 | finance.yahoo.comAIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comAIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 15, 2024 | globenewswire.comKellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM BoardNovember 14, 2024 | finance.yahoo.comInsights into AIM ImmunoTech's Upcoming EarningsNovember 14, 2024 | benzinga.comExploring AIM ImmunoTech's Earnings ExpectationsNovember 7, 2024 | benzinga.com Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address AIM Media Mentions By Week AIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIM News Sentiment▼0.290.41▲Average Medical News Sentiment AIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIM Articles This Week▼32▲AIM Articles Average Week Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PDSB News SPRO News OPTN News ELEV News DYAI News IVVD News ICCC News CELU News XLO News ACHL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AIM) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIM Stock Alerts